These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 6683587)
1. Inhibition of amino acid transport by cis-diamminedichloroplatinum(II) derivatives in L1210 murine leukemia cells. Scanlon KJ; Safirstein RL; Thies H; Gross RB; Waxman S; Guttenplan JB Cancer Res; 1983 Sep; 43(9):4211-5. PubMed ID: 6683587 [TBL] [Abstract][Full Text] [Related]
2. Amino acid membrane transport properties of L1210 cells resistant to cisplatin. Gross RB; Scanlon KJ Chemioterapia; 1986 Feb; 5(1):37-43. PubMed ID: 3955782 [TBL] [Abstract][Full Text] [Related]
3. Differential uptake of cis-diamminedichloroplatinum (II) by sensitive and resistant murine L1210 leukemia cells. Waud WR Cancer Res; 1987 Dec; 47(24 Pt 1):6549-55. PubMed ID: 3677093 [TBL] [Abstract][Full Text] [Related]
4. Dinaline inhibits amino acid transport and proliferation of colon carcinoma cells in vitro. Schaider H; Haberkorn U; Stöhr M; Berger MR Anticancer Res; 1995; 15(6B):2501-9. PubMed ID: 8669814 [TBL] [Abstract][Full Text] [Related]
5. Quenching of DNA:platinum(II) monoadducts as a possible mechanism of resistance to cis-diamminedichloroplatinum(II) in L1210 cells. Micetich K; Zwelling LA; Kohn KW Cancer Res; 1983 Aug; 43(8):3609-13. PubMed ID: 6683124 [TBL] [Abstract][Full Text] [Related]
6. Properties of amino acid transport systems in K562 cells sensitive and resistant to cis-diamminedichloroplatinum(II). Shionoya S; Lu Y; Scanlon KJ Cancer Res; 1986 Jul; 46(7):3445-8. PubMed ID: 3708576 [TBL] [Abstract][Full Text] [Related]
7. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV). Yoshida M; Khokhar AR; Siddik ZH Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266 [TBL] [Abstract][Full Text] [Related]
8. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands. Kido Y; Khokhar AR; al-Baker S; Siddik ZH Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629 [TBL] [Abstract][Full Text] [Related]
9. A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase II activity. Barret JM; Calsou P; Larsen AK; Salles B Mol Pharmacol; 1994 Sep; 46(3):431-6. PubMed ID: 7935322 [TBL] [Abstract][Full Text] [Related]
10. Kinetics of formation and disappearance of a DNA cross-linking effect in mouse leukemia L1210 cells treated with cis- and trans-diamminedichloroplatinum(II). Zwelling LA; Kohn KW; Ross WE; Ewig RA; Anderson T Cancer Res; 1978 Jun; 38(6):1762-8. PubMed ID: 565680 [TBL] [Abstract][Full Text] [Related]
11. The inhibition of P338 lymphocytic leukemia DNA polymerase alpha activity by cis-diamminedichloroplatinum(II) and related derivatives. Oswald CB; Hall IH Anticancer Res; 1989; 9(4):915-22. PubMed ID: 2817817 [TBL] [Abstract][Full Text] [Related]
12. Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. Ishikawa T; Ali-Osman F J Biol Chem; 1993 Sep; 268(27):20116-25. PubMed ID: 8376370 [TBL] [Abstract][Full Text] [Related]
13. DNA synthesis, protein synthesis and platinum content following drug administration in cis-diamminedichloroplatinum(II) -sensitive and -resistant L1210 cells transferred from in vitro to in vivo conditions. Hanusovská E; Ujházy V Neoplasma; 1987; 34(6):721-6. PubMed ID: 3431611 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of methionine transport by methotrexate in mitogen-stimulated human lymphocytes. Scanlon KJ; Berkowitz K; Pallai ME; Waxman S Cancer Treat Rep; 1983; 67(7-8):631-9. PubMed ID: 6871881 [TBL] [Abstract][Full Text] [Related]
15. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of several amino nucleoside-platinum(II) complexes. Lin TS; Zhou RX; Scanlon KJ; Brubaker WF; Lee JJ; Woods K; Humphreys C; Prusoff WH J Med Chem; 1986 May; 29(5):681-6. PubMed ID: 3701784 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of methionine uptake by methotrexate in mouse leukemia L1210 cells. Scanlon KJ; Cashmore AR; Kashani-Sabet M; Pallai M; Dreyer RN; Moroson BA; Saketos M Cancer Chemother Pharmacol; 1987; 19(1):21-4. PubMed ID: 3102093 [TBL] [Abstract][Full Text] [Related]
18. The role of methionine in methotrexate-sensitive and methotrexate-resistant mouse leukemia L1210 cells. Scanlon KJ; Kashani-Sabet M; Cashmore AR; Pallai M; Moroson BA; Saketos M Cancer Chemother Pharmacol; 1987; 19(1):25-9. PubMed ID: 3815722 [TBL] [Abstract][Full Text] [Related]
19. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines. Yoshida M; Khokhar AR; Siddik ZH Cancer Res; 1994 Jul; 54(13):3468-73. PubMed ID: 8012968 [TBL] [Abstract][Full Text] [Related]
20. Platinum incorporation and differential effects of cis- and trans-diamminedichloroplatinum(II) on the growth of mouse leukemia P388/D1. Just G; Holler E Cancer Res; 1989 Dec; 49(24 Pt 1):7072-7. PubMed ID: 2582449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]